Chikungunya in Brazil: An epidemic of high cost for private healthcare, 2017

• Published in: Tropical medicine & international health Vol. 27; no. 10; pp. 925 - 933
• Main Authors: Margarette Oliveira de Andrade, Maria, Almeida Barreto, Francisca Kalline, Coelho, Tania Maria Silva, Praça Pinto, Geovana, Queiroz, Isabella Timbo, Nogueira, Camila Távora, Freitas, Andre Ricardo Ribas, Ferreira, Marcelo Jose Monteiro, Alencar, Carlos Henrique, Góes Cavalcanti, Luciano Pamplona
• Format: Journal Article
• Language: English
• Published: Oxford Blackwell Publishing Ltd 01.10.2022
• Subjects: Absenteeism; Arthralgia; Chikungunya virus; cost analysis; cost of illness; Economic factors; Economics; Emergency medical care; Emergency medical services; Employee benefits; Epidemics; Fever; Health care; Hospitals; Medical personnel; Patients; Population studies; private hospitals; Sick leave; Signs and symptoms; Vector-borne diseases; Brazil
• ISSN: 1360-2276; 1365-3156; 1365-3156
• DOI: 10.1111/tmi.13810

Objective We evaluated the impact of direct and indirect medical costs incurred through chikungunya infections in patients treated in Fortaleza, Brazil. Methods Cross‐sectional study about the cost of illness. The valuation method of medical costs was based on the micro‐costing approach (bottom‐up). The study was carried out in a large general hospital of the private health network. The study population consisted of patients treated as suspected cases of chikungunya and hospital professionals who applied for sick leave due to chikungunya. Results In 2017, there were 2683 patients treated at this hospital who incurred an estimated cost of $383,514.40. From this amount, $174,322.91 (45.5%) were expended on emergency care, $194,700.59 (50.8%) on hospitalisations. 123 hospital professionals were infected with chikungunya and sick leave duration ranged between 1 and 19 days. Health professionals generated 746 days of absence and an amount of $14,490.90 due to absenteeism from work related to chikungunya. 31 symptoms were reported, especially arthralgia (91.1%) and fever (79.4%). There was a predominance of females (58.8%) and the age group of 20–39 years (42.1%). Conclusion The average cost of admissions was over $2400. Considering the epidemic potential of chikungunya, our data indicate the huge economic burden of this disease to healthcare units in the presence of epidemics. Economic factors, added to the loss of life and the consequences of chronic chikungunya, make this disease a real scourge for countries with fewer material resources.